As International Sales Manager at Guangzhou Wexis Biotech Limited, Andrea is responsible for developing strategic partnerships and expanding the company's presence across Europe, the Middle East, Southeast Asia, and Africa.
She works closely with channel partners and customers to strengthen long-term relationships, support market development, and gain valuable insights into clinical workflows through regular business engagement and on-site visits. Andrea also leads Wexis' participation at major international exhibitions and pathology congresses, where she engages with healthcare professionals, identifies emerging market trends, and helps shape the company's commercial strategy.
Working in collaboration with regulatory and quality teams, Andrea supports market access initiatives by helping ensure compliance with IVDR and local regulatory requirements, enabling the successful introduction of Wexis' histopathology solutions into international markets.
Her focus is on delivering sustainable business growth by combining customer partnership, market intelligence, and regulatory readiness to support pathology laboratories around the world.
Keith W. Jones MCIEx is an experienced international business consultant with more than three decades of expertise in global sales, business development, export strategy and international channel management within the medical technology, laboratory and life sciences sectors.
As International Business Consultant to Guangzhou Wexis Biotech, Keith advises on all aspects of the company's international business strategy, supporting the journey from product development and commercialisation through to global market expansion. Working closely with the executive team, he contributes to strategic planning, international marketing, distributor development, market access and the establishment of long-term commercial partnerships across Europe, the Middle East, Asia-Pacific and other key international markets.
Throughout his career, Keith has successfully introduced innovative laboratory, pathology and diagnostic technologies into international healthcare markets, developing extensive networks of distributors, laboratory professionals, healthcare providers and industry partners. His experience encompasses strategic market assessment, international sales management, channel development, product positioning, customer engagement and business growth, enabling organisations to successfully expand their global presence.
Keith combines commercial insight with a practical understanding of the challenges involved in bringing innovative technologies to market. His collaborative approach helps ensure that research and development activities are aligned with market requirements, customer needs and sustainable international growth opportunities.
A full Member of the Chartered Institute of Export & International Trade (MCIEx), Keith is passionate about helping innovative healthcare technology companies build successful international businesses through strong partnerships, customer-focused strategies and effective global market development.
Mr. Alfred is an experienced business executive with over three decades of leadership in the medical technology, laboratory diagnostics and life sciences sectors. His extensive expertise spans international business development, sales and marketing, product commercialisation and strategic consultancy across Greater China and global markets.
As an International Business Consultant to Guangzhou Wexis Biotech, Alfred provides strategic guidance on international market development, product commercialisation and the expansion of global distribution networks.
Alfred's career includes 18 years as Managing Director of Worldtech Medical Supplies Ltd., where he successfully established and managed the supply and distribution of medical and laboratory equipment in the China market. He subsequently served as Business Director for Thermo Fisher Scientific in Shanghai, leading sales and marketing operations throughout Greater China while identifying new product opportunities and strategic business partnerships.
In addition to his consultancy work with Wexis Biotech, Alfred serves as Vice President of RHT International Ltd., where he leads the international development of NCCO technology. His work focuses on expanding global distribution, evaluating new applications for NCCO technology, supporting specialised customer solutions and advancing research into its medical and healthcare applications.
Drawing on decades of commercial and technical experience, Alfred is dedicated to helping innovative healthcare technology companies achieve sustainable international growth through strategic partnerships, customer-focused innovation and effective global market development.
